82 results
SC 14D9
EX-99
MOR
Morphosys AG
11 Apr 24
Tender offer solicitation
11:57am
the International Financial Reporting Standards (“IFRS”) published by the International Accounting Standards Board (“IASB”) and those adopted by the European Union … and Settlement of the Offer for MorphoSys Securities
5.6.1
Acceptance of the Offer Outside Germany, the Member States of the European Union
SC TO-T
EX-99
MOR
Morphosys AG
11 Apr 24
Third party tender offer statement
6:01am
of the Federal Republic of Germany, the Member States of the European Union and the European Economic Area
The Offer relates to shares in a German … the Federal Republic of Germany, the Member States of the European Union and the European Economic Area and the United States may be subject to legal
SC TO-T
EX-99
MOR
Morphosys AG
11 Apr 24
Third party tender offer statement
6:01am
abode in the United States of America or otherwise outside the Federal Republic of Germany, the Member States of the European Union and the European … or elsewhere outside of the Federal Republic of Germany, the Member States of the European Union and the European Economic
Area
1.4
Publication
6-K
EX-99.1
MOR
Morphosys AG
20 Mar 24
Current report (foreign)
4:12pm
standards endorsed by the European Union (EU) for external purposes. The financial statements are subject to a number of preparation, auditing … MorphoSys AG – Planegg — Annual Financial Statements as of December 31, 2023
UNION INVESTMENT PRIVATFONDS GmbH, ON NOVEMBER 23, 2023 1. Issuer
6-K
EX-99.1
MOR
Morphosys AG
13 Mar 24
Non-Financial Group Report 2023
4:12pm
Legal and HR Officer. Focus in 2023 In 2023, we consolidated our eDPO services for activities conducted within the European Union by our affiliate … was published in the Official Journal of the European Union (EU) on June 22, 2020, and entered into force on July 12, 2020, is a key component of the Action
6-K
EX-99.1
0vsyzy4s
13 Mar 24
Current report (foreign)
4:08pm
6-K
EX-99.3
c4wbowttj42
7 Feb 24
MorphoSys Enters into Business Combination Agreement to be
6:57am
6-K
vihgw1haz
24 Nov 23
Current report (foreign)
6:04am
6-K
EX-99.1
pnl 42u0p
24 Nov 23
Current report (foreign)
6:04am
F-3ASR
EX-5.1
v2fjbeu4dheq6sx7n4jp
16 Nov 23
Automatic shelf registration (foreign)
9:27am
F-3ASR
7tf2spxoq
16 Nov 23
Automatic shelf registration (foreign)
9:27am
6-K
EX-99.1
vc4en6rg1cpmrcl
16 Nov 23
Half-Year Report JANUARY – JUNE
9:25am
6-K
786gytk27
7 Nov 23
Current report (foreign)
10:05am
6-K
EX-99.1
i7p55ah464476dn6h8fa
7 Nov 23
Current report (foreign)
10:05am
6-K
EX-99.1
795zmxhw7 041rz
10 Aug 23
Half-Year Report JANUARY – JUNE 2023
8:51am
6-K
EX-99.1
5qxywuy3qez sysoqa
31 Aug 22
MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
4:08pm
6-K
EX-99.1
7459gkusc10g8bl
3 Aug 22
Half-Year Report JANUARY – JUNE 2022
4:36pm
6-K
EX-99.1
sskcfkxq p0q8yt
23 Mar 22
Current report (foreign)
4:15pm